These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 19540398

  • 1. Relationship between neointimal coverage of sirolimus-eluting stents and lesion characteristics: a study with serial coronary angioscopy.
    Yamamoto M, Okamatsu K, Inami S, Takano M, Yokoyama S, Ohba T, Ibuki C, Hata N, Seino Y, Mizuno K.
    Am Heart J; 2009 Jul; 158(1):99-104. PubMed ID: 19540398
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vulnerable disease may induce neointimal coverage after sirolimus-eluting stent implantation.
    Nishino M, Hoshida S, Taniike M, Kato H, Egami Y, Shutta R, Yamaguchi H, Tanaka K, Tanouchi J, Yamada Y.
    Am Heart J; 2010 Sep; 160(3):564-9. PubMed ID: 20826267
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, Kashiwase K, Ogasawara N, Hirotani S, Kodama K.
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [Abstract] [Full Text] [Related]

  • 9. The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
    Yamamoto M, Takano M, Murakami D, Inami T, Kobayashi N, Inami S, Okamatsu K, Ohba T, Ibuki C, Hata N, Seino Y, Jang IK, Mizuno K.
    Am Heart J; 2011 Jun; 161(6):1200-6. PubMed ID: 21641369
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Coronary angioscopic findings 9 months after everolimus-eluting stent implantation compared with sirolimus-eluting stents.
    Dai K, Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Miura F, Nakama Y, Otani T, Ooi K, Ikenaga H, Nakamura M, Miki T, Kishimoto S, Sumimoto Y.
    J Cardiol; 2013 Jan; 61(1):22-30. PubMed ID: 23078862
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y.
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [Abstract] [Full Text] [Related]

  • 13. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC, Otto S, Gassdorf J, Janiak F, Danzer C, Ferrari M, Figulla HR.
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [Abstract] [Full Text] [Related]

  • 14. Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy.
    Sera F, Awata M, Uematsu M, Kotani J, Nanto S, Nagata S.
    JACC Cardiovasc Interv; 2009 Oct; 2(10):989-94. PubMed ID: 19850260
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX, Ma FY, Luo W, Xie WL, Sun SH, Guo XM, Wang F, Zhao XZ, Chu XW.
    Zhonghua Yi Xue Za Zhi; 2006 Apr 25; 86(16):1102-6. PubMed ID: 16796834
    [Abstract] [Full Text] [Related]

  • 17. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography.
    Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, Sawada T, Paredes OL, Hirata K, Yokoyama M.
    Eur Heart J; 2007 Apr 25; 28(8):961-7. PubMed ID: 17135281
    [Abstract] [Full Text] [Related]

  • 18. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
    Tanaka N, Terashima M, Rathore S, Itoh T, Habara M, Nasu K, Kimura M, Itoh T, Kinoshita Y, Ehara M, Tsuchikane E, Asakura K, Asakura Y, Katoh O, Suzuki T.
    JACC Cardiovasc Interv; 2010 Oct 25; 3(10):1074-9. PubMed ID: 20965467
    [Abstract] [Full Text] [Related]

  • 19. Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.
    Oyabu J, Ueda Y, Ogasawara N, Okada K, Hirayama A, Kodama K.
    Am Heart J; 2006 Dec 25; 152(6):1168-74. PubMed ID: 17161071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.